Skip to main content

Table 1 Included studies

From: Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease

Author (year)

Recruitment setting

Study information

Psychiatric comorbidity information

Intervention

Outcomes

Intervention

Comparator

Duration

Anxiety

Outcome

Tolerability

Stokes [19]

Setting

Specialty Clinic

Study design

Randomized controlled trial

Study population

Chronic Enteritis or Ulcerative Colitis

Screening tool

Hamilton Anxiety Rating Scale (HAM)

Moderate to severe anxious mood, and 3 anxiety-related symptoms on HAM

Global rating scaleModerate anxiety

Pharmacologic

Lorazepam 1 mg QAM 2 mg QHS (n = 24)

Provider delivering intervention

Gastroenterologist

Placebo (n = 21)

4 weeks

Hamilton Anxiety Rating Scale

Lipman-Rickels 35-item Self-rating scale

Global rating scale

Difference in mean scores

Discontinuation rate

Rate of adverse effects